Percentage of Respondents Routinely Providing Child and Adolescent Vaccines On Site, Referring Elsewhere, or Neither Providing nor Referring for Specific Vaccines (n = 582)
| Vaccine | Provide in Practice | Sometimes or Always Refer | Neither Give nor Refer |
|---|---|---|---|
| DTaP = Diphtheria and tetanus toxoids and acellular pertussis; MMR = measles-mumps-rubella; Tdap = tetanus toxoid and reduced-strength diphtheria toxoid and acellular pertussis. | |||
| Note: row totals may add to more than 100% because respondents may have checked, for example, that they provide a vaccine in their practice, as well as that they sometimes refer it. | |||
| a Did not specify between conjugate meningococcal vaccine and polysaccharide meningococcal vaccine. | |||
| DTaP | 88.7 | 11.0 | 3.8a |
| Haemophilus influenzae type b | 80.6 | 16.0 | 6.0 |
| Hepatitis A virus | 79.6 | 18.0 | 5.5 |
| Hepatitis B virus | 90.1 | 10.6 | 3.4 |
| Human papillomavirus | 83.9 | 15.6 | 4.5 |
| Inactivated poliovirus | 79.2 | 16.6 | 6.5 |
| Influenza | 93.8 | 6.3 | 2.9 |
| MMR | 84.9 | 13.6 | 4.5 |
| Neisseria meningitidisa | 79.6 | 20.2 | 4.5 |
| Pneumococcal | 94.2 | 5.3 | 2.9 |
| Pneumococcal polysaccharide vaccine | 82.5 | 14.9 | 6.0 |
| Rotavirus | 45.5 | 33.8 | 22.0 |
| Tdap | 90.6 | 9.8 | 3.1 |
| Varicella | 81.6 | 17.0 | 5.0 |